Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Nitrofluorescein, Isomer 1 (AC181)
Cat.#: ASSD-181
Specifications
Description Nitrofluorescein, Isomer 1 is a fluorescent labeling reagent for proteins which is used in the fluorescent antibody technique for rapid identification of pathogens. Synonyms 5-Nitrofluorescein Size 1 g Molecule Weight 377.3 Molecular formula C20H11NO7 CAS Number 3326-35-0 Solubility Soluble in Acetone and Methanol Form Crystalline Storage Store at -20° C Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ASSD-203 Bis(2,2′-bipyridine)-4,4′-dicarboxybipyridine-ruthenium di(N-succinimidyl ester) bis(hexafluorophosphate) (AC203) 5 mg inquiry ASSD-112 Propidium Iodide Staining Solution (1mg/ml) in water (AC112) 1 mL inquiry ASSD-131 Calcein Blue (AC131) 1 mg inquiry ASSD-188 Dansyl Chloride (AC188) 1 g inquiry ASSD-145 Oxazole Yellow Iodide 1mM solution (in 1mL DMSO) (AC145) 1 mL inquiry ASSD-187 Quinaldine Red (AC187) 5 g, 25 g, 100 g, 250 g inquiry ASSD-170 BAPTA-AM (AC170) 25 mg inquiry ASSD-200 Ethylenediamine N-[(Cyanine 3) Monofunctional Hexanoic Acid]-N′-[3-difluoromethyl-4-phosphoanilinamidosuccinic Acid] Diamide (AC200) 500 μg inquiry ASSD-162 Nile Red (AC162) 25 mg inquiry ASSD-118 BrdU (5-Bromo-2′-deoxyuridine) (AC118) 200 mg, 100 mg, 1 g, 5g inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket